XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating expenses:    
Research and development $ 2,353 $ 1,678
General and administrative 17,519 3,467
Revaluation of contingent royalty obligation payable to Evolus Founders, a related party 4,913 900
Depreciation and amortization 484 0
Total operating expenses 25,269 6,045
Loss from operations (25,269) (6,045)
Other income (expense):    
Interest income 389 0
Interest expense (618) (107)
Loss before income taxes (25,498) (6,152)
Income tax (benefit) expense (14,523) 10
Net loss (10,975) (6,162)
Other comprehensive loss:    
Unrealized loss on available-for-sale securities, net of tax (9) 0
Comprehensive loss $ (10,984) $ (6,162)
Net loss per share, basic and diluted (in dollars per share) $ (0.40) $ (0.30)
Weighted-average shares outstanding used to compute basic and diluted net loss per share (in shares) 27,330,174 20,226,460